In ovarian cancer and uterine serous carcinoma cell lines, the pro metastatic oncogene c-Myc [78, 79], which upregulates H19 [80], is also its indirect target, due to removal of c-Myc let-7-mediated repression. The gene discussed is MYC; the disease is endometrial serous adenocarcinoma.